Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 73 results.
User Information
Export Records
  1. 1.   Generation and characterization of mature hepatocyte organoids for liver metabolic studies
  2. Liu, Yuchen; Zhou, Yaxing; Ahodantin, James; Jin, Yu; Zhu, Juanjuan; Sun,David; Wu,Xiaolin; Su, Lishan; Yang, Yingzi
  3. Journal of Cell Science. 2024, May 15; 137(10):
  1. 2.   Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
  2. Cecchi, Fabiola; Rex, Karen; Schmidt, Joanna; Vocke, Cathy D; Lee, Young H; Burkett, Sandra; Baker, Daniel; Damore, Michael A; Coxon, Angela; Burgess, Teresa L; Bottaro, Donald P
  3. Cancers. 2023, Jan 11; 15(2):
  1. 3.   HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
  2. Zerbato, Jennifer M; Avihingsanon, Anchalee; Singh, Kasha P; Zhao, Wei; Deleage,Claire; Rosen, Elias; Cottrell, Mackenzie L; Rhodes, Ajantha; Dantanarayana, Ashanti; Tumpach, Carolin; Tennakoon, Surekha; Crane, Megan; Price, David J; Braat, Sabine; Mason, Hugh; Roche, Michael; Kashuba, Angela D M; Revill, Peter A; Audsley, Jennifer; Lewin, Sharon R
  3. EBioMedicine. 2022, Dec 08; 87: 104391.
  1. 4.   Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger
  2. Peng, F.; Tao, Q. F.; Wu, X. M.; Dou, H.; Spencer, S.; Mang, C. Y.; Xu, L.; Sun, L. L.; Zhao, Y.; Li, H. B.; Zeng, S.; Liu, G. M.; Hao, X. J.
  3. Fitoterapia. 2012, Apr; 83(3): 568-585.
  1. 5.   Large-scale fine mapping of the HNF1B locus and prostate cancer risk
  2. Berndt, S. I.; Sampson, J.; Yeager, M.; Jacobs, K. B.; Wang, Z. M.; Hutchinson, A.; Chung, C.; Orr, N.; Wacholder, S.; Chatterjee, N.; Yu, K.; Kraft, P.; Feigelson, H. S.; Thun, M. J.; Diver, W. R.; Albanes, D.; Virtamo, J.; Weinstein, S.; Schumacher, F. R.; Cancel-Tassin, G.; Cussenot, O.; Valeri, A.; Andriole, G. L.; Crawford, E. D.; Haiman, C.; Henderson, B.; Kolonel, L.; Le Marchand, L.; Siddiq, A.; Riboli, E.; Travis, R. C.; Kaaks, R.; Isaacs, W.; Isaacs, S.; Wiley, K. E.; Gronberg, H.; Wiklund, F.; Stattin, P.; Xu, J. F.; Zheng, S. L.; Sun, J. L.; Vatten, L. J.; Hveem, K.; Njolstad, I.; Gerhard, D. S.; Tucker, M.; Hayes, R. B.; Hoover, R. N.; Fraumeni, J. F.; Hunter, D. J.; Thomas, G.; Chanock, S. J.
  3. Human Molecular Genetics. 2011, Aug; 20(16): 3322-3329.
  1. 6.   In Vivo Consequences of Liver-Specific Interleukin-22 Expression in Mice: Implications for Human Liver Disease Progression
  2. Park, O.; Wang, H.; Weng, H. L.; Feigenbaum, L.; Li, H.; Yin, S.; Ki, S. H.; Yoo, S. H.; Dooley, S.; Wang, F. S.; Young, H. A.; Gao, B.
  3. Hepatology. 2011, Jul; 54(1): 252-261.
  1. 7.   A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology
  2. Gao, Y. D.; Majumdar, D.; Jovanovic, B.; Shaifer, C.; Lin, P. C.; Zijlstra, A.; Webb, D. J.; Li, D. Y.
  3. Biomedical Microdevices. 2011, Jun; 13(3): 539-548.
  1. 8.   Variation in innate immunity genes and risk of multiple myeloma
  2. Purdue, M. P.; Lan, Q.; Menashe, I.; Zheng, T. Z.; Zhang, Y. W.; Yeager, M.; Hosgood, H. D.; Zahm, S. H.; Chanock, S. J.; Rothman, N.; Baris, D.
  3. Hematological Oncology. 2011, Mar; 29(1): 42-46.
  1. 9.   RSK-Mediated Phosphorylation in the C/EBP beta Leucine Zipper Regulates DNA Binding, Dimerization, and Growth Arrest Activity
  2. Lee, S.; Shuman, J. D.; Guszczynski, T.; Sakchaisri, K.; Sebastian, T.; Copeland, T. D.; Miller, M.; Cohen, M. S.; Taunton, J.; Smart, R. C.; Xiao, Z.; Yu, L. R.; Veenstra, T. D.; Johnson, P. F.
  3. Molecular and Cellular Biology. 2010, Jun; 30(11): 2621-2635.
  1. 10.   Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation
  2. Lee, S. L.; Huang, P. Y.; Roller, P.; Cho, E. G.; Park, D.; Dickson, R. B.
  3. Mechanisms of Development. 2010, Jan-Feb; 127(1-2): 82-95.
  1. 11.   CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression
  2. Tomita, T.; Kido, T.; Kurotani, R.; Iemura, S. I.; Sterneck, E.; Natsume, T.; Vinson, C.; Kimura, S.
  3. Journal of Biological Chemistry. 2008 283(37): 25617-25627.
  1. 12.   Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1
  2. Li, P.; Jiang, S.; Lee, S. L.; Lin, C. Y.; Johnson, M. D.; Dickson, R. B.; Michejda, C. J.; Roller, P. P.
  3. Journal of Medicinal Chemistry. 2007, Nov; 50(24): 5976-5983.
  1. 13.   The pregnane X receptor gene-humanized mouse: A model for investigating drug-drug interactions mediated by cytochromes P450 3A
  2. Ma, X.; Shah, Y.; Cheung, C.; Guo, G. L.; Feigenbaum, L.; Krausz, K. W.; Idle, J. R.; Gonzalez, F. J.
  3. Drug Metabolism and Disposition. 2007, Feb; 35(2): 194-200.
  1. 14.   Identification of the genes for kidney cancer: Opportunity for disease-specific targeted therapeutics
  2. Linehan, W. M.; Pinto, P. A.; Srinivasan, R.; Merino, M.; Choyke, P.; Choyke, L.; Coleman, J.; Toro, J.; Glenn, G.; Vocke, C.; Zbar, B.; Schmidt, L. S.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2007, Jan; 13(2): 671S-679S.
  1. 15.   Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic Met receptor
  2. Mood, K.; Saucier, C.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Molecular Biology of the Cell. 2006, Sep; 17(9): 3717-3728.
  1. 16.   Oncogenic Met receptor induces ectopic structures in Xenopus embryos
  2. Ishimura, A.; Lee, H. S.; Bong, Y. S.; Saucier, C.; Mood, K.; Park, E.; Daar, I. O.
  3. Oncogene. 2006, Jul; 25(31): 4286-4299.
  1. 17.   Stop and go - Anti-proliferative and mitogenic functions of the transcription factor C/EBP beta
  2. Sebastian, T.; Johnson, P. F.
  3. Cell Cycle. 2006, May; 5(9): 953-957.
  1. 18.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 19.   Species-specific effects of the hepatocarcinogens 3 '-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver
  2. Merkulova, T. I.; Kropachev, K. Y.; Timofeeva, O. A.; Vasiliev, G. V.; Levashova, Z. B.; Ilnitskaya, S. I.; Kobzev, V. F.; Pakharukova, M. Y.; Bryzgalov, L. O.; Kaledin, V. I.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 223-232.
  1. 20.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 21.   Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice
  2. Liu, J.; He, Y. Y.; Chignell, C. F.; Clark, J.; Myers, P.; Saavedra, J. E.; Waalkes, M. P.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 144-151.
  1. 22.   The CYP2E1-humanized transgenic mouse: Role of CYP2E1 in acetaminophen hepatotoxicity
  2. Cheung, C.; Yu, A. M.; Ward, J. M.; Krausz, K. W.; Akiyama, T. E.; Feigenbaum, L.; Gonzalez, F. J.
  3. Drug Metabolism and Disposition. 2005, MAR; 33(3): 449-457.
  1. 23.   The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level
  2. Qu, W.; Liu, J.; Fuquay, R.; Shimoda, R.; Sakurai, T.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P.
  3. Nitric Oxide-Biology and Chemistry. 2005, MAR; 12(2): 114-120.
  1. 24.   Intra- and intercellular variations in the repair efficiency of O-6-methylguanine, and their contribution to kinetic complexity
  2. Souliotis, V. L.; Sfikakis, P. P.; Anderson, L. M.; Kyrtopoulos, S. A.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2004, DEC 21; 568(2): 155-170.
  1. 25.   Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
  2. Graveel, C.; Su, Y. L.; Koeman, J.; Wang, L. M.; Tessarollo, L.; Fiscella, M.; Birchmeier, C.; Swiatek, P.; Bronson, R.; Woude, G. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, DEC 7; 101(49): 17198-17203.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel